Found: 11
Select item for more details and to access through your institution.
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy.
- Published in:
- Oncologist, 2024, v. 29, n. 10, p. 894, doi. 10.1093/oncolo/oyae110
- By:
- Publication type:
- Article
COVID-19-related mortality in cancer patients in an Irish setting.
- Published in:
- Irish Journal of Medical Science, 2022, v. 191, n. 5, p. 2013, doi. 10.1007/s11845-021-02815-9
- By:
- Publication type:
- Article
Delivery of systemic anti-cancer therapy during the COVID-19 pandemic.
- Published in:
- Irish Journal of Medical Science, 2022, v. 191, n. 2, p. 559, doi. 10.1007/s11845-021-02631-1
- By:
- Publication type:
- Article
Chemotherapy in the Covid-19 era: the patient's perception.
- Published in:
- Irish Journal of Medical Science, 2021, v. 190, n. 4, p. 1303, doi. 10.1007/s11845-020-02457-3
- By:
- Publication type:
- Article
Targeting KRAS in Pancreatic Cancer.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 11, p. 1870, doi. 10.3390/jpm12111870
- By:
- Publication type:
- Article
Advanced Bile Duct Cancers: A Focused Review on Current and Emerging Systemic Treatments.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1800, doi. 10.3390/cancers14071800
- By:
- Publication type:
- Article
Top advances in esophageal/gastroesophageal junction cancers in 2021.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 10, p. 1894, doi. 10.1002/cncr.34140
- By:
- Publication type:
- Article
Outcomes and Molecular Features of Brain Metastasis in Gastroesophageal Adenocarcinoma.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 8, p. e2228083, doi. 10.1001/jamanetworkopen.2022.28083
- By:
- Publication type:
- Article
Clinical Utility of 18 F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 11, p. 1884, doi. 10.3390/diagnostics13111884
- By:
- Publication type:
- Article
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1429, doi. 10.1093/jnci/djae095
- By:
- Publication type:
- Article
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications.
- Published in:
- 2022
- By:
- Publication type:
- journal article